Metal‐Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection
Small · 2024
DOI: 10.1002/smll.202308286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Yanan Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, 330006, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Metal-Organic Frameworks, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: First Affiliated Hospital of Nan-Chang University Clinical Research and Cultivation Project, Postdoctoral Fellowship Program of CPSF, National Natural Science Foundation of China.
Abstract (Originalsprache)
The prevalence of drug‐resistant bacteria presents a significant challenge to the antibiotic treatment of Helicobacter pylori ( H. pylori ), while traditional antimicrobial agents often suffer from shortcomings such as poor gastric retention, inadequate alleviation of inflammation, and significant adverse effects on the gut microbiota. Here, a selenized chitosan (CS‐Se) modified bismuth‐based metal‐organic framework (Bi—MOF@CS‐Se) nanodrug is reported that can target mucin through the charge interaction of the outer CS–Se layer to achieve mucosal adhesion and gastric retention. Additionally, the Bi—MOF@CS‐Se can respond to gastric acid and pepsin degradation, and the exposed Bi—MOF exhibits excellent antibacterial properties against standard H. pylori as well as clinical antibiotic‐resistant strains. Remarkably, the Bi—MOF@CS‐Se effectively alleviates inflammation and excessive oxidative stress by regulating the expression of inflammatory factors and the production of reactive oxygen species (ROS), thereby exerting therapeutic effects against H. pylori infection. Importantly, this Bi—MOF@CS‐Se nanodrug does not affect the homeostasis of gut microbiota, providing a promising strategy for efficient and safe treatment of H. pylori infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, 330006, China.
- Institute of Digestive Disease, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, 330006, China.
- College of Chemistry of Nanchang University, Nanchang University, Nanchang, 330031, China.
- Postdoctoral Innovation Practice Base, The First Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, 330006, P. R. China.
ORCID-Profile: Xiaolei Wang, Yin Zhu
Förderung
- First Affiliated Hospital of Nan-Chang University Clinical Research and Cultivation Project
- Postdoctoral Fellowship Program of CPSF
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Y., Zhang, W., He, C., Shu, C., Xu, X., Wang, H., Fei, X., Li, N., Hu, Y., Xie, C., Lu, N., Wang, X., & Zhu, Y. (2024). Metal‐Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection. Small. https://doi.org/10.1002/smll.202308286
Vancouver
Zhou Y, Zhang W, He C, Shu C, Xu X, Wang H, et al. Metal‐Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection. Small. 2024. doi:10.1002/smll.202308286
BibTeX
@article{Zhou2024,
author = {Zhou, Yanan and Zhang, Wei and He, Cong and Shu, Chunxi and Xu, Xinbo and Wang, Huan and Fei, Xiao and Li, Nianshuang and Hu, Yi and Xie, Chuan and Lu, Nonghua and Wang, Xiaolei and Zhu, Yin},
title = {Metal‐Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202308286}
}
EUVIMED